Neurotransmitters in the TME: Can Dopamine and Glutamate Be the Next Cancer Targets?. (2026). Journal of Biomolecules, Pathogenesis and Therapeutics, 2(3), 111-112. https://doi.org/10.68041/jbpt.v2i3/01